Novartis has announced that its chief executive, Joseph Jimenez, plans to step down from the role in January 2018, and to retire from the company on Aug. 31, 2018. Vasant (Vas) Narasimhan, the company's global head of drug development and chief medical officer, has been chosen by Novartis' board of ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.